Top Story

Induction therapy conferred no survival benefit in locally advanced thymomas

April 28, 2015

SEATTLE — Induction therapy prior to surgery does not extend survival or reduce recurrence among patients with locally advanced thymomas, according to results of a retrospective review presented at the American Association for Thoracic Surgery Annual Meeting.

Giovanni Leuzzi, MD, a thoracic surgeon at IRCCS Regina Elena National Cancer Institute in Rome, and colleagues reviewed data on 370 patients treated at 38 institutions. All patients underwent surgery for stage III thymomas (WHO classification A to B3).

Meeting News Coverage

Prolonged overnight fasting may reduce breast cancer risk

April 28, 2015
PHILADELPHIA — Prolonged nighttime fasting may reduce glycemic markers that are associated with an increased risk for breast cancer, according to study results…
Meeting News Coverage

Adjuvant chemotherapy associated with shorter survival in LCNEC

April 27, 2015
SEATTLE — Patients who underwent adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinomas demonstrated poorer 3-year survival than those who did…
VIDEO: T-cell immunotherapy may induce durable remissions in post-HSCT lymphoproliferative disorder Meeting News CoverageVideo

VIDEO: T-cell immunotherapy may induce durable remissions in post-HSCT lymphoproliferative disorder

April 27, 2015
Richard J. O’Reilly, MD, chairman of the department of pediatrics at Memorial Sloan Kettering Cancer Center, provides an overview of trials evaluating a large…
Medicare’s new payment system gives physicians two options Health Care Legislative and Regulatory Update

Medicare’s new payment system gives physicians two options

April 27, 2015
The Medicare Access and CHIP Reauthorization Act, signed into law on April 16, will make major changes in Medicare payments for physician services. Things start out…
More News Headlines »
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
Meeting News Coverage Video
VIDEO: Ipilimumab plus nivolumab conferred high response rates in melanoma

VIDEO: Ipilimumab plus nivolumab conferred high response rates in melanoma

April 27, 2015
F. Stephen Hodi, Jr., MD, director of the melanoma center at Dana-Farber Cancer Institute and associate professor of…
More »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
morganatic-roan